Addex Therapeutics Ltd. (ADXN) stock
ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.06−0.44 (-12.57%)
Close on Nov 18, 2026Market cap $62.83KP/E –Yield –
Addex Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was CHF 29.97K, down 92.6% from the year before. The highest annual figure on record is CHF 6.04M in fiscal 2018.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | CHF 29.97K | -92.6% |
| FY2024 | Dec 31, 2024 | CHF 404.10K | -74.9% |
| FY2023 | Dec 31, 2023 | CHF 1.61M | +13.4% |
| FY2022 | Dec 31, 2022 | CHF 1.42M | -51.2% |
| FY2021 | Dec 31, 2021 | CHF 2.92M | -19.3% |
| FY2020 | Dec 31, 2020 | CHF 3.61M | +30.8% |
| FY2019 | Dec 31, 2019 | CHF 2.76M | -54.3% |
| FY2018 | Dec 31, 2018 | CHF 6.04M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | CHF 115.28K | – |
| Q2 FY2023 | Jun 30, 2023 | CHF 630.88K | – |
| Q2 FY2022 | Jun 30, 2022 | CHF 183.35K | – |
| Q2 FY2021 | Jun 30, 2021 | CHF 992.60K | – |
See a number that looks wrong?